H. B. Fuller (NYSE:FUL) Upgraded by Zacks Research to “Strong-Buy” Rating

Posted by Brian Himes on Aug 26th, 2026

Zacks Research upgraded shares of H. B. Fuller (NYSE:FUL – Free Report) from a hold rating to a strong-buy rating in a report issued on Monday morning,Zacks.com reports.

A number of other brokerages also recently weighed in on FUL. Deutsche Bank Aktiengesellschaft increased their price objective on shares of H. B. Fuller from $70.00 to $72.00 and gave the company a “buy” rating in a research report on Tuesday, June 30th. The Goldman Sachs Group set a $67.00 price target on H. B. Fuller in a report on Friday, June 26th. Citigroup lifted their price objective on H. B. Fuller from $70.00 to $75.00 and gave the stock a “buy” rating in a report on Tuesday, June 30th. Raymond James Financial set a $67.00 target price on H. B. Fuller in a report on Friday, June 26th. Finally, Royal Bank Of Canada set a $58.00 target price on H. B. Fuller in a research report on Wednesday, May 27th. Two investment analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, H. B. Fuller has a consensus rating of “Buy” and a consensus price target of $67.86.

Get Our Latest Report on FUL

H. B. Fuller Price Performance

NYSE FUL opened at $57.02 on Monday. H. B. Fuller has a one year low of $48.71 and a one year high of $68.63. The stock has a 50-day moving average of $58.92 and a 200 day moving average of $60.41. The company has a debt-to-equity ratio of 1.00, a quick ratio of 1.12 and a current ratio of 1.80. The company has a market capitalization of $3.07 billion, a price-to-earnings ratio of 17.49, a PEG ratio of 0.63 and a beta of 0.98.

H. B. Fuller (NYSE:FUL – Get Free Report) last posted its earnings results on Thursday, June 25th. The specialty chemicals company reported $1.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.37 by $0.04. The business had revenue of $950.27 million for the quarter, compared to analysts’ expectations of $924.83 million. H. B. Fuller had a net margin of 5.29% and a return on equity of 12.18%. The business’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.18 EPS. On average, sell-side analysts forecast that H. B. Fuller will post 4.87 EPS for the current year.

H. B. Fuller Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, August 13th. Stockholders of record on Thursday, July 30th were given a dividend of $0.245 per share. The ex-dividend date of this dividend was Thursday, July 30th. This represents a $0.98 dividend on an annualized basis and a dividend yield of 1.7%. H. B. Fuller’s payout ratio is presently 30.06%.

Insider Activity at H. B. Fuller

In other news, VP Nathan D. Weaver sold 9,561 shares of the company’s stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $62.06, for a total value of $593,355.66. Following the completion of the sale, the vice president directly owned 11,739 shares in the company, valued at $728,522.34. This represents a 44.89% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. 1.83% of the stock is owned by company insiders.

Institutional Trading of H. B. Fuller

Hedge funds have recently bought and sold shares of the stock. Strs Ohio bought a new position in shares of H. B. Fuller in the first quarter worth about $101,000. EverSource Wealth Advisors LLC increased its holdings in H. B. Fuller by 129.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,218 shares of the specialty chemicals company’s stock worth $73,000 after acquiring an additional 688 shares in the last quarter. Baird Financial Group Inc. increased its holdings in H. B. Fuller by 19.6% in the 2nd quarter. Baird Financial Group Inc. now owns 7,518 shares of the specialty chemicals company’s stock worth $452,000 after acquiring an additional 1,232 shares in the last quarter. Marshall Wace LLP raised its stake in H. B. Fuller by 382.1% during the 2nd quarter. Marshall Wace LLP now owns 20,370 shares of the specialty chemicals company’s stock worth $1,225,000 after acquiring an additional 16,145 shares during the period. Finally, Cerity Partners LLC lifted its holdings in H. B. Fuller by 2.3% during the second quarter. Cerity Partners LLC now owns 11,499 shares of the specialty chemicals company’s stock valued at $692,000 after purchasing an additional 261 shares in the last quarter. Institutional investors own 95.93% of the company’s stock.

H. B. Fuller Company Profile

(Get Free Report)

H. B. Fuller Company, founded in 1887 and headquartered in St. Paul, Minnesota, is a global adhesives and specialty chemical solutions provider serving a wide array of industries. The company develops, manufactures and markets adhesive technologies, sealants, polymers and related chemical products designed to enhance product performance, sustainability and manufacturing efficiency.

Fuller’s product portfolio spans multiple market segments, including packaging and converting, general industrial assembly, electronics, transportation, hygiene and construction.